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Abstract: The UK Stop Smoking Services (SSS) are a source of information and advice on
e-cigarettes for smokers and thus it is important to understand the knowledge of, and attitudes
towards, e-cigarettes held by stop smoking practitioners. The datasets were English SSS quarterly
monitoring returns (n = 207,883) and an online survey of English SSS practitioners, managers, and
commissioners between 26th November and 15th December 2014 (n = 1801). SSS monitoring data
suggested 2% of clients were using e-cigarettes to quit with SSS and that clients using e-cigarettes
had similar quit rates to clients using Varenicline. Most SSS personnel are waiting for licenced
e-cigarettes to become available before they will recommend them to clients. However, less than a
quarter view e-cigarettes as “a good thing”. Managers and commissioners were more positive than
practitioners. SSS personnel working for the NHS (hospitals and GP surgeries) were less positive
about e-cigarettes than those employed elsewhere. E-cigarettes were cited as the most important
reason for the recent decline in service footfall. Thus dissemination of information about e-cigarettes
needs to be examined and services should address their stance on e-cigarettes with some urgency.
Keywords: e-cigarettes; stop smoking services; cessation; harm reduction
1. Introduction
E-cigarettes usually provide nicotine and potentially act as a replacement for smoking. They
are battery powered devices that aim to simulate tobacco cigarettes, essentially by heating a solution
containing nicotine into an inhalable aerosol [1,2]. Available evidence, so far, suggests that e-cigarettes
are much safer than tobacco because the constituents of cigarette smoke that are harmful are either
absent or present at much lower levels in e-cigarettes and the chemicals present in e-cigarettes have
not, at least as yet, been shown to be harmful [3–5]. They have also not become a significant gateway
to smoking cigarettes for non-smokers [4]. Furthermore at least some types of e-cigarettes might help
smokers to quit or at least reduce their cigarette use [3,5,6]. Meta-analysis of randomised control
trials [7] has shown that e-cigarettes are similar in efficacy to patches for quitting and are better than
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patches for reducing the number of cigarettes smoked and quitting and harm reduction are more
likely when e-cigarettes contain nicotine; however the small number of trials means that more trials
are required. In 2015 there were about 2.6 million e-cigarette users in Great Britain [8]. Among a
survey sample of smokers and ex-smokers in England a fifth were current users and a third had tried
them [9]. E-cigarettes are now, by a considerable margin, the approach to quitting most favoured by
smokers in England [10].
A small proportion of smokers (about 5% of those making a quit attempt [10]) are willing to
access local stop smoking services (SSS) for help with their quit attempt, but this still amounted
to 450,582 clients in 2014/2015 [11]. SSS treated 816,444 smokers in 2011/12 [11] and thus use has
almost halved between 2011/12 and 2014/15. At the same time e-cigarette use has grown, however,
during this period the SSS have also undergone other changes such as being transferred from the
NHS to Local Authorities. Nevertheless, smokers attending SSS have a greater chance of quitting
than smokers attempting to stop by using medication or willpower alone [12–14] and a growing
number of countries are offering cessation support [15]. Thus the reported experience of smokers
already willing to use SSS, a cessation aid which has empirical support [16], regarding e-cigarettes
may be particularly valuable.
The National Centre for Smoking Cessation Training (NCSCT) recommends that SSS “be open
to electronic cigarette use in people keen to try them; especially in those that have tried, but not
succeeded, in stopping smoking with the use of licensed stop smoking medicines” [17]. However
the safety of e-cigarettes is still debated [18] and the ensuing confusion among potential consumers
may be the reason for the current plateauing of growth [19,20]. Previous research suggests that SSS
are a source of information and advice on e-cigarettes for smokers [21] and as such it is important to
understand the knowledge of, and attitudes towards, e-cigarettes held by stop smoking practitioners.
The aims of this paper are to explore:
‚ Reported extent and efficacy of e-cigarette use among Stop Smoking Service clients
‚ SSS personnel’s knowledge and attitudes towards e-cigarettes and which groups are more likely
to be positive about e-cigarettes
‚ Whether SSS personnel view e-cigarettes as having an impact on the recent reduction in SSS use
by smokers wishing to quit
2. Experimental Section
2.1. Data
2.1.1. Local Stop Smoking Services Quarterly Returns
Quarterly monitoring returns of the local stop smoking services data (April to June and July
to September 2014) were analysed. Four times a year, SSS send data on the number of clients who
have set a quit date (named a day when they will attempt to quit smoking) and how many of these
had quit smoking four weeks later to the NHS Health and Social Care Information Centre. Clients
can be counted in national monitoring data if they are an adult who has been smoking a tobacco
product daily or an adolescent who has been smoking a tobacco product weekly and they have not
quit smoking more than 48 hours prior to attending their first session [12]. A client is regarded as a
four week quitter if they self-report that they have not smoked within the previous two weeks and
an expired air carbon monoxide test reading is 10ppm or below [12]. The information is originally
collected by each SSS client’s practitioner either electronically using data monitoring software or via
paper forms. Since 1st April 2013, this data collation has not been mandatory but the majority of
services continue to send information [12].
From 1st April 2014, services were asked to include whether SSS clients were using e-cigarettes
and similar products, such as nicotine strips for oral use, which together were called “unlicensed
nicotine containing products” in addition to continuing to record if they were using licensed
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medications (nicotine replacement therapy (NRT), Bupropion or Varenicline) [12]. Note that,
currently, e-cigarettes account for virtually all unlicensed nicotine containing products. Clients could
also use different combinations of licenced and unlicensed products and these are also recorded.
2.1.2. Online Survey
An e-bulletin was sent to 24,000 SSS practitioners, managers, and commissioners registered with
the NCSCT containing an invitation to participate and a link to an online survey. Practitioners directly
provide behavioural support for smokers wanting to quit. Managers may have direct contact with
smokers through supervising practitioners. Commissioners work for the local authority and make
decisions about who will run the service and are less likely to have direct contact with clients. The
survey was completed 1801 times between 26 November and 15 December 2014. After exclusions
for missing data and locations outside England there were 1761 cases available for analysis. This
represents a 7% response rate or one in every 14 of those invited.
2.2. Analysis
The software used for analysis was SPSS version 22. The data collected in the online survey will
be deposited with the University of Bath Research Archive.
2.2.1. Local Stop Smoking Services Quarterly Returns
Frequencies and four-week quit rates were calculated by the nicotine containing product (NCP)
used. The categories available were single licensed NCP only, combination of licensed NCPs
concurrently, Bupropion (Zyban) only, Varenicline (Champix) only, licensed NCP and/ or Bupropion
(Zyban) and/or Varenicline (Champix) consecutively, combination of a licensed medication and an
unlicensed NCP concurrently, licensed medication and an unlicensed NCP consecutively, unlicensed
NCP only, did not use any licensed medication, or unlicensed NCP, not known. Additionally, the
total setting quit dates and quitting for clients using an unlicensed NCP alone or in combination with
other medications was calculated. Clients who are lost to follow up are included in the denominator
in an “intention to treat” approach [22].
2.2.2. Online Survey
Univariate results and column percentages were tabulated. For most questions, respondents
were asked to tick as many as applied and for these the number and proportion that ticked each box
are tabulated. For some questions, clients were asked whether they agreed with a list of statements
and answered on a five point Likert scale. For analysis, these were dichotomised into strongly agree
and agree and compared with neither agree nor disagree, disagree, and strongly disagree.
Opinion of e-cigarettes was the dependent variable for most of the analysis. Opinion of
e-cigarettes was derived from responses to how much respondents agreed with the statement that
e-cigarettes are a good thing. Respondents who held a positive opinion of e-cigarettes if they said
they strongly agreed or agreed were compared with respondents who said they neither agreed
nor disagreed, disagreed, or strongly disagreed. Chi-square tests, with the continuity correction
applied for two by two tables, were conducted between opinion of e-cigarettes and sources of
information on e-cigarettes, (possible sources were NCSCT briefing and website, the news and
media, training courses, ASH briefing and website, WHO report on electronic cigarettes, experienced
electronic cigarette users, the websites of electronic cigarette companies, the websites of vaping
organisations); whether respondents agreed or strongly agreed (compared with neither agreed or
disagreed, disagreed or strongly disagreed) that: “e-cigarettes should not be recommended by SSS
until there is good evidence on safety and effectiveness”, “if an e-cig was a licensed medication,
I would definitely recommend them to clients”, “e-cigarettes should only be available as a licensed
medication”, “e-cigarettes normalise cigarette smoking”, “over the past twelve months, I’ve become
less positive about e-cigarettes”, “e-cigarettes are a good thing”, “e-cigarettes should be able to
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be bought anywhere by smokers as a consumer product” and “e-cigarettes denormalise cigarette
smoking”; client groups to which respondents would recommend e-cigarettes (possible groups were
all my clients, clients who are already using e-cigarettes, clients wishing to cut down but not stop,
clients wanting to use electronic cigarettes at times when they cannot smoke (temporary abstinence),
clients who wish to cut down before they stop, clients who have tried and failed to quit many
times, more dependent smokers, none of my clients); region of England (North East, North West,
Yorkshire & Humberside, East Midlands, West Midlands, East of England, London, South East,
South West), employer organization (General Practice, Pharmacy, Acute/Foundation Hospital Trust,
Employed directly by the Local Authority, Mental Health Trust, Private company, Social enterprise,
Other) and professional role (Commissioner, Manager, Stop Smoking Practitioner, Other). Regional
differences have been found for preferred tobacco product [23] and smoking prevalence [24] and area
differences have been found for smoking cessation [13]. Thus regional differences for e-cigarettes
were plausible and included in the analysis. Differences have also been found for cessation according
to stop smoking service provider [13,25] so employer organisation was included and analysed. In
preparation for multivariate analyses chi-square tests were also conducted between each of the
variables and professional role in the services.
There was also univariate analyses of reasons for the decline in e-cigarette use (reasons were
smokers choosing to use e-cigarettes, remaining smokers in the population are harder to reach,
reduced mass media health campaigns, reduced funding of services, SSS moved from NHS to LA,
SSS put out to tender and few specialist practitioners available).
2.2.3. Multivariate Analysis—Which Variables Affect the Association between Role in the Service
and Opinion of E-Cigarettes
Logistic regression analysis, with opinion on e-cigarettes as the outcome, was carried out.
Variables were candidates to be included in the model where they were significantly associated with
opinion on e-cigarettes and role in the services in bivariate analysis. The following stages took place:
Firstly, cases which were missing on any variable, or whose role in the service was “other” were
excluded leaving 1278 cases. Secondly, each variable was placed alone in the model. Thirdly, each
variable was placed in the model with role in the service and the change in the odds ratio of role in the
service was noted. Fourthly, the variables were added in a stepwise fashion; variables were entered
in the order of the size of the difference made to the odds ratio of role in the service in the second
stage. When the odds ratio of role in the service was non-significant (p < 10) no more independent
variables were entered into the model. The relative importance of the variables was checked using
backwards stepwise entry.
3. Results and Discussion
3.1. Local Stop Smoking Services Quarterly Returns
Of the 207,883 clients who set quit dates between April and September 2014, 4750 reported
using electronic cigarettes (Table 1). There were 874 clients who reported using electronic cigarettes
only, 3122 who used them concurrently with a licenced medication and 874 who reported used
them consecutively with a licenced medication (the data does not allow us to determine whether
e-cigarettes were used first or second). Self report quit rates for those using electronic cigarettes (59%)
were higher than general (50%) and similar to those using Varenicline alone (60%).
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Table 1. English local Stop Smoking Services monitoring data April to September 2014.
Type of Pharmacotherapy Set QuitDate
Quit at 4
Weeks % Quit
Total 207,883 103,899 50%
Single NCP only 60,513 28,954 48%
Combination of licensed NCPs concurrently 62,771 28,728 46%
Bupropion (Zyban) only 1047 582 56%
Varenicline (Champix) only 53,215 32,002 60%
Licensed NCP and/or Bupropion (Zyban) and/or Varenicline (Champix) consecutively 3542 1674 47%
Combination of a licensed medication and an unlicensed NCP concurrently 3122 1756 56%
Licensed medication and an unlicensed NCP consecutively 754 464 62%
Unlicensed NCP only 874 570 65%
Did not use any licensed medication or unlicensed NCP 11,716 6314 54%
Not known 10,329 2855 28%
Unlicensed NCP with and without other medication 4750 2790 59%
% Total clients using NCP 2% 3%
3.2. Online Survey
3.2.1. Respondent Knowledge and Attitudes
The most frequently mentioned source of information on e-cigarettes, mentioned by about
two-thirds of respondents, was the NCSCT and the second was news and media (Table 2). Over
half of respondents said they would not recommend e-cigarettes to any of their clients. Contrastingly,
less than 5% would recommend e-cigarettes to all their clients.
Respondents were asked whether they agreed with eight statements. Over three-quarters agreed
that that e-cigarettes should not be recommended by SSS until there is good evidence on safety and
effectiveness but two-thirds agreed that if they were licensed that they would recommend them and
nearly 60% agreed that they should only be available as a licensed medication. Just under a fifth
thought that e-cigarettes should be available anywhere as a consumer product. Only about half
agreed that e-cigarettes normalize cigarette smoking although only a tenth agreed that e-cigarettes
denormalise smoking. About a quarter of respondents had become less positive about e-cigarettes
over the last 12 months; nevertheless about a quarter also thought that e-cigarettes were a good thing.
The variables which were significantly associated with both role in the service and opinion of
e-cigarettes and were thus candidates for entry into the multivariate analyses were the following
sources of information: ASH briefing and website, WHO report on electronic cigarettes and
experienced e-cigarette users; the following statements: “Over the past 12 months I’ve become
less positive about e-cigarettes”, “if an e-cigarette was a licensed medication, I would definitely
recommend them to clients”, and “e-cigarettes denormalise cigarette smoking” and the final variable
was whether respondents would recommend clients wanting to use electronic cigarettes at times
when they cannot smoke (temporary abstinence).
3.2.2. Spread of Service Providers Stances on E-Cigarettes (Bivariate Analyses)
The largest regional representation was from London and the southeast and the smallest was
from the northeast (Table 3). Respondents working in London made up a higher proportion of those
positive about e-cigarettes compared with those in the north of England.
Nearly half of respondents were employed by GP practices or pharmacies whereas
managers/commissioners were most likely to be employed by a hospital trust or directly by a
local authority. Those employed by GPs and hospitals were less likely to hold a positive opinion
of e-cigarettes whereas those employed by mental health trusts or local authorities were more
positive. Nearly two-thirds of respondents were practitioners, 8% were managers, and 1% were
commissioners. Commissioners and managers made a larger than expected proportion of those
positive about e-cigarettes whereas practitioners made up a smaller than expected proportion.
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Table 2. Respondent knowledge and attitudes by role in services and opinion on e-cigarettes.
Variable Distribution Role in Services Opinion on E-Cigs
Manager/Commissioner Practitioner Sig. Agree “A Good Thing” Neutral/Disagree Sig.
N % N % N % N % N %
Sources of information on e-cigs
NCSCT briefing and website 1155 65.6 126 78.8 821 68.2 p = 0.009 281 65.5 863 65.9 p = 0.933
The news and media 797 45.3 74 46.3 549 45.6 p = 0.951 203 47.3 586 44.7 p = 0.380
Training courses 670 38.0 56 35.0 496 41.2 p = 0.155 165 38.5 501 38.2 p = 0.982
ASH briefing and website 585 33.2 109 68.1 383 31.8 p < 0.001 173 40.3 407 31.1 p = 0.001
WHO report on electronic cigarettes 517 29.4 74 46.3 320 26.6 p < 0.001 143 33.3 369 28.2 p = 0.048
Experienced electronic cigarette users 457 26.0 54 33.8 302 25.1 p = 0.025 169 39.4 285 21.8 p < 0.001
The websites of electronic cigarette companies 189 10.7 20 12.5 122 10.1 p = 0.436 61 14.2 127 9.7 p = 0.011
The websites of vaping organisations 114 6.5 26 16.3 63 5.2 p < 0.001 39 9.1 74 5.6 p = 0.017
Respondents agreed or strongly agreed (compared with neither
agreed or disagreed, disagreed or strongly disagreed) that:
E-cigs are a good thing? 429 24.4 60 38.0 264 22.2 p < 0.001
Over the past 12 months I've become less positive about
e-cigs 495 28.1 31 19.5 362 30.7 p = 0.005 34 8.0 457 35.2 p < 0.001
E-cigs should not be recommended by SSS until there is good
evidence on safety & effectiveness 1342 76.2 118 74.7 944 79.7 p = 0.180 234 54.9 1101 84.9 p < 0.001
If an e-cig was a licensed medication, I would definitely
recommend them to clients 1148 65.2 121 76.6 790 66.5 p = 0.014 375 88.0 765 58.9 p < 0.001
E-cigs should only be available as a licensed medication 1036 58.8 97 61.0 752 63.5 p = 0.597 164 38.7 863 66.6 p < 0.001
E-cigs should be able to be bought anywhere by smokers as
a consumer product 325 18.5 34 21.7 203 17.2 p = 0.202 193 45.7 130 10.0 p < 0.001
E-cigs normalise cigarette smoking 950 53.9 88 55.7 670 57.2 p = 0.791 140 33.3 804 62.4 p < 0.001
E-cigs denormalise cigarette smoking 190 10.8 29 19.5 118 10.3 p = 0.001 66 15.9 124 9.9 p = 0.001
Client groups to which respondents would recommend e-cigarettes
All my clients 82 4.7 10 6.3 45 3.7 p = 0.193 58 13.5 23 1.8 p < 0.001
Clients who are already using e-cigs 324 18.4 40 25.0 219 18.2 p = 0.051 138 32.2 184 14.0 p < 0.001
Clients wishing to cut down but not stop 215 12.2 24 15.0 139 11.6 p = 0.258 104 24.2 111 8.5 p < 0.001
Clients wanting to use electronic cigarettes at times when
they cannot smoke (temporary abstinence) 212 12.0 31 19.4 131 10.9 p = 0.003 105 24.5 107 8.2 p < 0.001
Clients who wish to cut down before they stop 204 11.6 22 13.8 129 10.7 p = 0.312 101 23.5 102 7.8 p < 0.001
Clients who have tried and failed to quit many times 355 20.2 34 21.3 236 19.6 p = 0.703 167 38.9 187 14.3 p < 0.001
More dependent smokers 199 11.3 23 14.4 118 9.8 p = 0.100 98 22.8 100 7.6 p < 0.001
None of my clients 983 55.8 82 51.2 693 57.6 p = 0.150 122 28.4 850 64.9 p < 0.001
16162
Int. J. Environ. Res. Public Health 2015, 12, 16157–16167
Table 3. Stances of service providers on e-cigarettes.
Variable Role in Services Opinion of E-Cigs
Total Manager/Commissioner Practitioner Agree “A Good Thing” Neutral/Disagree
N % N % N % N % N %
Region p = 0.026 p = 0.015
North East 64 3.6 5 10.4 43 89.6 10 15.6 54 84.4
North West 230 13.1 23 12.6 159 87.4 47 20.6 181 79.4
Yorkshire & Humberside 132 7.5 7 7.0 93 93.0 24 18.5 106 81.5
East Midlands 159 9.0 6 5.1 112 94.9 40 25.2 119 74.8
West Midlands 224 12.7 19 10.8 157 89.2 50 22.9 168 77.1
East of England 151 8.6 14 12.5 98 87.5 35 23.5 114 76.5
London 290 16.5 32 14.5 189 85.5 94 32.6 194 67.4
South East 303 17.2 40 16.9 196 83.1 81 27.1 218 72.9
South West 208 11.8 14 8.2 156 91.8 48 23.5 156 76.5
Total 1761 100.0 160 11.7 1203 88.3 429 24.7 1310 75.3
Organisation p < 0.001 p < 0.001
General Practice 477 27.1 5 1.3 377 98.7 78 16.6 393 83.4
Pharmacy 334 19.0 25 8.9 257 91.1 83 25.2 247 74.8
Acute / Foundation Hospital Trust 255 14.5 29 16.3 149 83.7 47 18.8 203 81.2
Employed directly by the Local Authority 163 9.3 33 24.6 101 75.4 53 32.9 108 67.1
Mental Health Trust 105 6.0 16 21.3 59 78.7 45 43.7 58 56.3
Private company 104 5.9 15 18.8 65 81.3 36 35.0 67 65.0
Social enterprise 56 3.2 8 16.0 42 84.0 16 28.6 40 71.4
Other 267 15.2 29 15.9 153 84.1 71 26.8 194 73.2
Total 1761 100.0 160 11.7 1203 88.3 429 24.7 1310 75.3
Role p < 0.001
Commissioner 23 1.3 14 63.6 8 36.4
Manager 137 7.8 46 33.8 90 66.2
Other 398 22.6 105 26.9 286 73.1
Stop Smoking Practitioner 1203 68.3 264 22.2 926 77.8
Total 1761 100.0 429 24.7 1310 75.3
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Both region and organisation were significantly associated with the role the respondent played
in the services and their opinion of e-cigarettes. Thus both these variables were put forward for the
multivariate analyses.
3.2.3. Why might Commissioners and Managers be more Positive about E-Cigarettes than
Practitioners? (Multivariate Analysis)
There were 1278 cases available for multivariate analysis out of the 1363 clients who indicated
they were a practitioner, manager, or commissioner (Table 4). Managers/commissioners were
approximately twice as likely to agree/strongly agree that e-cigarettes were a good thing as
commissioners (OR 2.15 (1.50 to 3.08)) when role was alone in the model (Table 4). The variable
that caused the largest decline in the odds ratio of role when it was entered individually was the
employing organisation followed by agreement that the respondent had become less positive in the
last year.
When the variables were added in a forward stepwise manner, role became non-significant
(p < 0.05) when three variables were added and non-significant (p < 0.10) when four variables were
added. Thus there was no generalizable difference in opinion on e-cigarettes of practitioners and
managers/commissioners once these four variables had been taken into account. Removing each of
the four variables individually confirmed the order of magnitude difference made to the odds ratio of
role. The most important variable was employing organisation followed by agreement of becoming
less positive in the last year, then recommendation for temporary abstinence, and finally agreement
that they would recommend e-cigarettes if they were licenced.
In summary, managers/commissioners were more positive about e-cigarettes than practitioners;
they were also more likely to work directly for local authorities rather than GP practices, they were
less likely to say they had become less positive about e-cigarettes in the last year and they were
more likely to say that they would recommend them for temporary abstinence and that they would
recommend them to clients if they were licenced.
Items that did not appear to be mediators included information source about e-cigarettes, the
region worked in, whether or not e-cigarettes denormalise smoking and client groups to which they
would recommend cigarettes (other than temporary abstinence).
Table 4. Reasons for manager/commissioners more positive view of e-cigarettes (strongly
agree/agree that e-cigarettes are a good thing compared with neutral, disagree, or strongly disagree)
rather than practitioners suggested from logistic regression models—final mediating variables.
Variable
aOR of
Manager/Practitioner
When Variables Added in
Forward Stepwise
Significance of
Role
aOR of Manager/Practitioner
When Variables Removed
from Full Model Individually
(Backwards Stepwise)
Role (manager/commissioner vs practitioner) only 2.15 (1.50 to 3.08)
Organisation 1.82 (1.24 to 2.65) p = 0.002 1.60 (1.07 to 2.37)
Agree less positive in the last year 1.59 (1.07 to 2.36) p = 0.022 1.57 (1.05 to 2.35)
Recommend e-cigs for temporary abstinence 1.47 (0.98 to 2.20) p = 0.064 1.49 (0.99 to 2.23)
Agree would recommend if licenced 1.39 (0.91 to 2.10) 1 p = 0.124 1.47 (0.98 to 2.20)
1 This was the adjusted odds ratio (aOR) of role in the final model. In the final model respondents who were
employed by mental health trusts and employed directly by local authorities were significantly more likely
to have a good opinion of e-cigarettes than those employed by GP practices (aOR 3.41 (1.82 to 6.37) and 1.86
(1.12 to 3.12) respectively), respondents who agreed that they had become less positive in the last year were
significantly less likely to have a good opinion of e-cigarettes generally (aOR 0.16 (0.11 to 0.26)), respondents
who would recommend e-cigarettes for temporary abstinence or if they were licenced were significantly more
likely to have a good opinion of e-cigarettes (aOR 2.78 (1.89 to 4.07 and aOR 3.93 (2.68 to 5.77) respectively).
3.2.4. Role of E-Cigarettes in Decline in SSS Uptake
E-cigarettes were seen as the most important reason for the decline in numbers attending the SSS
followed by remaining smokers being harder to reach (Table 5). Thus the substantial changes in the
structure and funding of SSS were less commonly cited as reasons for the decline.
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Table 5. Reasons for the decline in SSS client numbers.
Reason N %
Smokers choosing to use e-cigs 1461 83.0
Remaining smokers in the population are harder to reach 947 53.8
Reduced mass media health campaigns 527 29.9
Reduced funding of services 488 27.7
SSS moved from NHS to LA 389 22.1
Put out to tender 299 17.0
Few specialist practitioners available 243 13.8
4. Conclusions
E-cigarettes were reported as being used by a very small proportion of SSS clients, but those
clients were among the most successful. Nevertheless, most SSS personnel were waiting for licenced
e-cigarettes to become available before recommending them to clients and less than a quarter viewed
e-cigarettes as “a good thing”. This is probably because evidence of effectiveness has only been
recently acquired [4]. A vaping promotion organisation survey of 84 medical professionals [26] found
generally positive opinions on e-cigarettes but also some ambivalence; these findings have not been
peer reviewed.
Managers and commissioners were more positive about e-cigarettes than practitioners.
Multivariate analysis in our study suggested that reasons for the association between role and positive
feelings towards e-cigarettes might include that, firstly, practitioners were more likely to work for GP
practices where staff were generally more negative whereas managers/commissioners were more
likely to work directly for a local authority or mental health trust where staff were generally more
positive. Secondly, practitioners were more likely to say they have become less positive in the
last 12 months than personnel in other roles. Thirdly, managers and commissioners were more
likely to recommend e-cigarettes for temporary abstinence than practitioners—this could be due
to a wider role in tobacco control and links to networks disseminating evidence and guidance on
e-cigarettes and more time to peruse new research whereas practitioners may be more focussed on
their cessation role. Such differences perhaps reflect lack of dissemination of information which could
be addressed by services. Innovation and improvement are most likely when there is greater sharing
of information [27]. SSS personnel cited e-cigarettes as the most important reason for the decline in
service footfall. Thus services should address their stance on e-cigarettes with some urgency.
In a study of adolescent health care professionals in Minnesota (U.S.), family medicine physicians
knew more about e-cigarettes and were more comfortable about talking to patients about them
than nurses [28] implying again that higher status professionals might be more positive; however
paediatricians had similar ratings to nurses which might suggest varying interests and networks of
different groups could play a role.
4.1. Limitations
High quit rates from e-cigarettes uncovered from the monitoring data could be because
e-cigarettes were more likely to be encouraged by services with higher quit rates generally or because
of self-selection bias. Asking about e-cigarettes was a new question on monitoring returns so it was
possible that use was under reported.
The online survey was very simple which meant some types of differentiation were not possible.
For example, only cases with an IP address outside England or who commented that they were based
elsewhere could be excluded. Thus some respondents who worked outside England could have been
included if they picked a random English region (which would also reduce the accuracy of the region
variable). Additionally we were unable to differentiate respondents who worked only for the SSS
from personnel who were employed in another role (for example a health care assistant for a GP
practice or pharmacy) which involved some smoking cessation behavioural support work.
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A different issue is that we do not know the source of SSS personnel’s opinions—we do
not know the extent to which respondents’ ideas were from personal experience with clients or
from general media for example. Additionally, it is unclear the extent to which the gap between
managers/commissioners and practitioners is the result of practitioners having less understanding
of the scientific literature on e-cigarettes or practitioners having a better understanding because they
see clients who vape day to day—and thus whether it is managers/commissioners or practitioners
who are more “correct” or closer to “the truth” in their beliefs.
The data analysis in this article was cross-sectional rather than longitudinal. Tracking changes
over time would be useful in future work.
4.2. Summary
Despite a positive approach being taken towards e-cigarettes by Public Health England [4]
and the NCSCT [12], in 2014 their use was not being encouraged by many English SSS and use
was only recorded by a small proportion of clients. SSS commissioners and managers need to
consider how to disseminate messages about e-cigarettes effectively to all practitioners and to address
practitioners’ concerns.
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